EXCERPT

In an effort to vault genetics into a new era of big data, six drug companies say they will decode the genes of half a million Brits and then make the data public – all by 2020.

The plan will turn the UK Biobank, the source of the DNA samples, into the world's single biggest concentration of genetic and health data anywhere, giving scientists and drug companies a powerful tool for understanding diseases.